Prescription drug · NDA
Nuvaring NDC 50090-7663
etonogestrel and ethinyl estradiol · Etonogestrel .12 mg/d; Ethinyl estradiol .015 mg/d · Insert, Extended release · Vaginal · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-7663-0 | 50090766300 | 1 POUCH in 1 BOX (50090-7663-0) / 21 d in 1 POUCHMarketed from Sep 30, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Nuvaring
- Generic name (nonproprietary)
- etonogestrel and ethinyl estradiol
- Active ingredients
- Etonogestrel — .12 mg/dEthinyl estradiol — .015 mg/d
- Dosage form
- Insert, Extended release
- Route
- Vaginal
- Labeler
- A-S Medication Solutions
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 021187
- Marketing start
- Listing expires
- Other FDA classes
- Estrogen Receptor Agonists (Mechanism)Progesterone Congeners (Chemical structure)
- Identifiers
- Product ID 50090-7663_0351867a-b894-4d2b-b167-981376693a10SPL ID 0351867a-b894-4d2b-b167-981376693a10SPL set ID 524c7188-ee84-4d5c-a6ab-e7a5ae36e22bRxCUI 1367436, 1367439UNII 304GTH6RNH, 423D2T571U
- Pharmacologic class
- Estrogen; Progestin
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N450090766300followed by a unit qualifier and the quantityPackage 50090-7663-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
FOR VAGINAL USE ONLY NuvaRing ® is indicated for use by females of reproductive age to prevent pregnancy. NuvaRing is an estrogen/progestin combination hormonal contraceptive (CHC) indicated for use by women to prevent pregnancy. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 021187
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Etonogestrel/Ethinyl Estradioletonogestrel and ethinyl estradiol | Etonogestrel .12 mg/d; Ethinyl estradiol .015 mg/d | Insert, Extended releaseVaginal | A-S Medication Solutions | 50090-5959 |
| NuvaRingetonogestrel and ethinyl estradiol | Etonogestrel .12 mg/d; Ethinyl estradiol .015 mg/d | Insert, Extended releaseVaginal | Organon LLC | 78206-146 |
| Nuvaringetonogestrel and ethinyl estradiol | Etonogestrel .12 mg/d; Ethinyl estradiol .015 mg/d | Insert, Extended releaseVaginal | A-S Medication Solutions | 50090-5611 |
| NuvaRingetonogestrel and ethinyl estradiol | Etonogestrel .12 mg/d; Ethinyl estradiol .015 mg/d | Insert, Extended releaseVaginal | Advanz Pharma (US) Corp. | 59212-146 |
| Etonogestrel/Ethinyl Estradioletonogestrel and ethinyl estradiol | Etonogestrel .12 mg/d; Ethinyl estradiol .015 mg/d | Insert, Extended releaseVaginal | Prasco Laboratories | 66993-605 |